The global Sepsis Diagnostics market size is expected to be worth around US$ 2.18 billion by 2030, according to a new report by Vision Research Reports.
The global Sepsis Diagnostics market size was valued at US$ 630.73 million in 2020 and is anticipated to grow at a CAGR of 9.10% during forecast period 2021 to 2030.
The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected to propel market growth over the forecast period.
Sepsis is a bloodstream disease that occurs as a result of a response to pathogenic microorganisms present in the blood. Patients suffering from this disease experience severe inflammation, which leads to prolonged hospitalization. According to the WHO, around 30 million people are estimated to be affected by this disease every year. The NCBI stated that the largest number of this condition has been observed in the youngest and oldest age groups. Thus, there is a rising need for the early diagnosis of this disease. The WHO reported that every year, 1.2 million children and 3 million newborns are affected by this disease across the world. This has further boosted the demand for its diagnostic tools for quick results and improved patient outcomes.
Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions for sepsis are expected to facilitate market growth over the forecast period. In May 2018, T2 Biosystems, Inc., a U.S.-based emerging diagnostic solutions company, received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens.
The outbreak of COVID-19 is another important factor boosting the demand for sepsis diagnostics around the globe. Symptoms of sepsis such as multiorgan injuries develop in around 2.0% to 5.0% of COVID-19 cases 8 to 10 days post-hospitalization, based on the estimates of the Global Sepsis Alliance. To manage this situation, the Biomedical Advanced Research and Development Authority, in May 2020, extended its partnership with Beckman Coulter for the development of a digital algorithm to detect sepsis in patients with COVID-19.
In 2020, the blood culture media segment accounted for the largest share of 41.65% and is expected to maintain its lead over the forecast period. This is because blood culture is considered to be the most convenient and cost-effective mode of testing by clinicians. Based on product, the market is segmented into instruments, blood culture media, assay kits and reagents, and software.
The software segment is anticipated to register the highest CAGR over the forecast period. This high growth is attributed to an increase in the adoption of innovative software platforms by healthcare providers for better diagnosis and management of sepsis. For instance, in September 2019, Guthrie, a U.S.-based integrated health care system, deployed Wolters Kluwer’s POC Advisor for the detection and treatment of sepsis at four area hospitals.
The microbiology segment held the largest share of 48.55% in 2020. This can be attributed to the fact that microbiology technology allows accurate detection and identification of microorganisms for sepsis diagnosis through the application of culture media tests. In addition, new strategic initiatives by key players are driving the segment over the forecast period. For instance, in April 2019, BD launched its new BD BACTEC platelet quality control media, which helps to identify and decrease the incidence of sepsis in patients receiving platelet transfusion. On the basis of technology, the market is segmented into microbiology, molecular diagnostics, immunoassays, and flow cytometry.
The molecular diagnostics segment is anticipated to expand at a lucrative CAGR over the forecast period. Increasing adoption of molecular diagnostic technology due to its several advantages, such as high sensitivity, accuracy, and less turnaround time, over other technologies is anticipated to drive the segment. However, a disadvantage of this technique is that it is unable to identify uncultivable organisms. Nevertheless, the molecular diagnostics technique is considered a standard pathogen identification technique after blood culture.
The bacterial sepsis segment held the largest share of 79.31% in 2020 and is anticipated to maintain its lead over the forecast period owing to its high prevalence. According to the study published by SAGE Journals in January 2019, bacterial sepsis is the most common type, with 62.2% of patients infected with gram-negative bacteria and 46.8% with gram-positive bacteria. Based on the pathogen, the market is segmented into bacterial sepsis, fungal sepsis, and others.
In the bacterial sepsis segment, the gram-negative bacteria segment is anticipated to dominate the market over the forecast period. Robust R&D activities and increasing regulatory approval of novel solutions are expected to significantly support the segment growth. For instance, in April 2019, GenMark Diagnostics, Inc. received the U.S. FDA approval for its new panel assay, developed to detect gram-negative bacteria causing sepsis.
Laboratory testing dominated the market in 2020 with an 84.86% share. This is mainly due to the fact that lab testing has greater accuracy in comparison to POC testing while diagnosing sepsis. Clinical laboratory testing provides an in-depth analysis of the pathogen and its drug resistance profile. In addition, routine testing of lactate levels, which are nonspecific, however, a useful marker of sepsis, is effectively performed in laboratory settings. With the advent of technologically advanced products, the reliance of the public and physicians on these labs has significantly increased. Based on testing type, the market is segmented into laboratory testing and POC testing.
POC testing is expected to witness significant growth over the forecast period due to the rapid diagnosis with assay kits. In addition, the introduction of novel point-of-care (POC) solutions for sepsis diagnosis is expected to support the growth of the PoC testing segment over the forecast period. For instance, in July 2018, Thermo Fisher Scientific Inc., a U.S.-based diagnostic solutions provider, launched its new B·R·A·H·M·S PCT, a direct point of care assay designed for the early diagnosis of bacterial infection and sepsis.
North America held the largest share of 40.8% in 2020 and is anticipated to maintain its lead throughout the forecast period. This can be attributed to the well-established healthcare infrastructure, which has led to an increase in the adoption of advanced diagnostic solutions in the region. In addition, the local presence of major players and a supportive reimbursement framework in this region are boosting the market growth. Furthermore, the high incidence of sepsis and infectious diseases is expected to fuel the demand for novel diagnostic solutions.
Asia Pacific is expected to exhibit an exponential CAGR during the forecast period. This can be attributed to the growing demand for sepsis diagnostic solutions in countries with a high prevalence of infectious diseases, such as China and India. The lucrative growth registered by this region is also believed to be an outcome of the increase in initiatives by regional and international players to improve access to novel laboratory automation solutions. However, a lack of awareness in some of the developing countries might restrain the market growth to some extent.
Becton, Dickinson and Company
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche AG
Danaher Corporation (Beckman Coulter, Inc.)
Amara Health Analytics
Wolters Kluwer N.V.
Epic Systems Corporation
Koninklijke Philips N.V.
Blood Culture Media
Assay Kits and Reagents
Testing Type Outlook
The Sepsis Diagnostics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Sepsis Diagnostics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Sepsis Diagnostics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sepsis Diagnostics market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Sepsis Diagnostics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Sepsis Diagnostics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Sepsis Diagnostics by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Sepsis Diagnostics market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Sepsis Diagnostics market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Sepsis Diagnostics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Sepsis Diagnostics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Sepsis Diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Sepsis Diagnostics market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Sepsis Diagnostics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Sepsis Diagnostics market. These factors have benefited the growth of the global market for Sepsis Diagnostics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Sepsis Diagnostics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Sepsis Diagnostics are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Respiratory Syncytial Virus (RSV) Diagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Bariatric Surgery Devices Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Zika Virus Testing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Wound Dressing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Blood Screening Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...